Sanofi breaks into first-line multiple myeloma with FDA approval for Sarclisa aliu Fri, 09/20/2024 – 15:43 More: Sanofi breaks into first-line multiple myeloma with FDA approval for Sarclisa Source: fierce
read moreWith FDA nod, AstraZeneca’s FluMist becomes first self-administered flu vaccine fkansteiner Fri, 09/20/2024 – 15:27 More: With FDA nod, AstraZeneca's FluMist becomes first self-administered flu vaccine Source: fierce
read moreBristol Myers Squibb axes 79 more in New Jersey as $1.5B cost-reduction program rolls on kdunleavy Fri, 09/20/2024 – 14:02 More: Bristol Myers Squibb axes 79 more in New Jersey as .5B cost-reduction program rolls on Source: fierce
read moreAfter prior snub, Zevra clinches FDA approval for rare lysosomal storage disorder drug Miplyffa fkansteiner Fri, 09/20/2024 – 13:44 More: After prior snub, Zevra clinches FDA approval for rare lysosomal storage disorder drug Miplyffa Source: fierce
read moreGilead taps Korea’s Yuhan to supply HIV drug ingredients in $81M deal zbecker Fri, 09/20/2024 – 10:41 More: Gilead taps Korea's Yuhan to supply HIV drug ingredients in M deal Source: fierce
read more© 1994 - 2026 B.M. Pharmaceuticals